• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一份用于基层医疗中遗传性乳腺癌识别的简易问卷的开发与验证

Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.

作者信息

Ashton-Prolla Patricia, Giacomazzi Juliana, Schmidt Aishameriane V, Roth Fernanda L, Palmero Edenir I, Kalakun Luciane, Aguiar Ernestina S, Moreira Susana M, Batassini Erica, Belo-Reyes Vanessa, Schuler-Faccini Lavinia, Giugliani Roberto, Caleffi Maira, Camey Suzi Alves

机构信息

Programa de Pós-Graduação em Genética e Biologia Molecular, Universidade Federal do Rio Grande do Sul , Porto Alegre, Brazil.

出版信息

BMC Cancer. 2009 Aug 14;9:283. doi: 10.1186/1471-2407-9-283.

DOI:10.1186/1471-2407-9-283
PMID:19682358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2739222/
Abstract

BACKGROUND

Breast cancer is a significant public health problem worldwide and the development of tools to identify individuals at-risk for hereditary breast cancer syndromes, where specific interventions can be proposed to reduce risk, has become increasingly relevant. A previous study in Southern Brazil has shown that a family history suggestive of these syndromes may be prevalent at the primary care level. Development of a simple and sensitive instrument, easily applicable in primary care units, would be particularly helpful in underserved communities in which identification and referral of high-risk individuals is difficult.

METHODS

A simple 7-question instrument about family history of breast, ovarian and colorectal cancer, FHS-7, was developed to screen for individuals with an increased risk for hereditary breast cancer syndromes. FHS-7 was applied to 9218 women during routine visits to primary care units in Southern Brazil. Two consecutive samples of 885 women and 910 women who answered positively to at least one question and negatively to all questions were included, respectively. The sensitivity, specificity and positive and negative predictive values were determined.

RESULTS

Of the 885 women reporting a positive family history, 211 (23.8%; CI95%: 21.5-26.2) had a pedigree suggestive of a hereditary breast and/or breast and colorectal cancer syndrome. Using as cut point one positive answer, the sensitivity and specificity of the instrument were 87.6% and 56.4%, respectively. Concordance between answers in two different applications was given by a intra-class correlation (ICC) of 0.84 for at least one positive answer. Temporal stability of the instrument was adequate (ICC = 0.65).

CONCLUSION

A simple instrument for the identification of the most common hereditary breast cancer syndrome phenotypes, showing good specificity and temporal stability was developed and could be used as a screening tool in primary care to refer at-risk individuals for genetic evaluations.

摘要

背景

乳腺癌是全球一个重大的公共卫生问题,开发用于识别遗传性乳腺癌综合征高危个体的工具变得越来越重要,因为可以针对这些个体提出特定干预措施以降低风险。巴西南部先前的一项研究表明,提示这些综合征的家族史在初级保健层面可能很普遍。开发一种简单且灵敏的工具,使其易于在初级保健单位应用,对于难以识别和转诊高危个体的服务不足社区将特别有帮助。

方法

开发了一种关于乳腺癌、卵巢癌和结直肠癌家族史的简单的7个问题的工具,即FHS-7,用于筛查遗传性乳腺癌综合征风险增加的个体。FHS-7应用于巴西南部初级保健单位常规就诊的9218名女性。分别纳入了连续的两个样本,即对至少一个问题回答为阳性且对所有问题回答为阴性的885名女性和910名女性。确定了敏感性、特异性以及阳性和阴性预测值。

结果

在报告有阳性家族史的885名女性中,211名(23.8%;95%置信区间:21.5-26.2)的家系提示存在遗传性乳腺癌和/或乳腺癌与结直肠癌综合征。以一个阳性回答作为切点,该工具的敏感性和特异性分别为87.6%和56.4%。对于至少一个阳性回答,两次不同应用中回答的一致性通过组内相关系数(ICC)为0.84给出。该工具的时间稳定性足够(ICC = 0.65)。

结论

开发了一种用于识别最常见遗传性乳腺癌综合征表型的简单工具,该工具显示出良好的特异性和时间稳定性,可作为初级保健中的筛查工具,用于将高危个体转诊进行基因评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b94c/2739222/716f7568c90d/1471-2407-9-283-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b94c/2739222/03ba2750844f/1471-2407-9-283-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b94c/2739222/716f7568c90d/1471-2407-9-283-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b94c/2739222/03ba2750844f/1471-2407-9-283-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b94c/2739222/716f7568c90d/1471-2407-9-283-2.jpg

相似文献

1
Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.一份用于基层医疗中遗传性乳腺癌识别的简易问卷的开发与验证
BMC Cancer. 2009 Aug 14;9:283. doi: 10.1186/1471-2407-9-283.
2
Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer.普通人群中遗传性癌症的识别:用于获取癌症家族史的筛查问卷的开发与验证
Cancer Med. 2017 Dec;6(12):3014-3024. doi: 10.1002/cam4.1210. Epub 2017 Oct 21.
3
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
4
Development and validation of a family history screening questionnaire in Australian primary care.澳大利亚初级保健中家族史筛查问卷的制定和验证。
Ann Fam Med. 2014 May-Jun;12(3):241-9. doi: 10.1370/afm.1617.
5
Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire.在一家基层医疗诊所中,使用自行填写问卷来调查乳腺癌和卵巢癌家族史的患病率。
Breast J. 2003 Jan-Feb;9(1):19-25. doi: 10.1046/j.1524-4741.2003.09105.x.
6
Breast cancer risk assessment: Evaluation of screening tools for genetics referral.乳腺癌风险评估:用于基因转诊的筛查工具评估
J Am Assoc Nurse Pract. 2019 Oct;31(10):562-572. doi: 10.1097/JXX.0000000000000272.
7
Hereditary and familial ovarian cancer in southern Ontario.安大略省南部的遗传性和家族性卵巢癌。
Cancer. 1994 Oct 15;74(8):2341-6. doi: 10.1002/1097-0142(19941015)74:8<2341::aid-cncr2820740819>3.0.co;2-z.
8
Hereditary breast cancer in Northern Ireland.北爱尔兰的遗传性乳腺癌。
Ulster Med J. 1996 Nov;65(2):113-7.
9
Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening.基于人群筛查的遗传性乳腺癌高危女性识别工具的验证
Cancer. 2006 Oct 15;107(8):1769-76. doi: 10.1002/cncr.22202.
10
A model to optimize public health care and downstage breast cancer in limited-resource populations in southern Brazil. (Porto Alegre Breast Health Intervention Cohort).在巴西南部资源有限人群中优化公共卫生保健及降低乳腺癌分期的模型(阿雷格里港乳腺健康干预队列)
BMC Public Health. 2009 Mar 13;9:83. doi: 10.1186/1471-2458-9-83.

引用本文的文献

1
Adaptation and pilot implementation of a hereditary cancer risk-assessment tool for primary care.一种用于初级保健的遗传性癌症风险评估工具的适应性调整与试点实施
BMC Prim Care. 2025 Aug 6;26(1):246. doi: 10.1186/s12875-025-02935-6.
2
Combining rare and common genetic variants improves population risk stratification for breast cancer.结合罕见和常见基因变异可改善乳腺癌的人群风险分层。
Genet Med Open. 2024 Feb 2;2:101826. doi: 10.1016/j.gimo.2024.101826. eCollection 2024.
3
Screening Familial Risk for Hereditary Breast and Ovarian Cancer.

本文引用的文献

1
Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern Brazil.巴西南部遗传性乳腺癌表型的人群流行率及遗传癌症风险评估计划的实施。
Genet Mol Biol. 2009 Jul;32(3):447-55. doi: 10.1590/S1415-47572009005000058. Epub 2009 Sep 1.
2
A model to optimize public health care and downstage breast cancer in limited-resource populations in southern Brazil. (Porto Alegre Breast Health Intervention Cohort).在巴西南部资源有限人群中优化公共卫生保健及降低乳腺癌分期的模型(阿雷格里港乳腺健康干预队列)
BMC Public Health. 2009 Mar 13;9:83. doi: 10.1186/1471-2458-9-83.
3
筛查遗传性乳腺癌和卵巢癌的家族风险。
JAMA Netw Open. 2024 Sep 3;7(9):e2435901. doi: 10.1001/jamanetworkopen.2024.35901.
4
BRCA testing and management of BRCA-mutated early-stage breast cancer: a comprehensive statement by expert group from GCC region.BRCA检测与BRCA突变早期乳腺癌的管理:海湾合作委员会地区专家组的综合声明
Front Oncol. 2024 Apr 25;14:1358982. doi: 10.3389/fonc.2024.1358982. eCollection 2024.
5
Design and pilot implementation of the Achieving Cancer Equity through Identification, Testing, and Screening (ACE-ITS) program in an urban underresourced population.在城市资源匮乏人群中开展通过识别、检测和筛查实现癌症公平(ACE-ITS)计划的设计和试点实施。
Cancer. 2023 Sep;129(S19):3141-3151. doi: 10.1002/cncr.34691.
6
Turning the Page on Breast Cancer in Ohio: Lessons learned from implementing a multilevel intervention to reduce breast cancer mortality among Black women.俄亥俄州乳腺癌防治工作的新篇章:实施多层次干预措施降低黑人女性乳腺癌死亡率的经验教训
Cancer. 2023 Sep;129(S19):3114-3127. doi: 10.1002/cncr.34845.
7
Clinical Considerations for the Integration of Adjuvant Olaparib into Practice for Early Breast Cancer: A Canadian Perspective.辅助奥拉帕利整合到早期乳腺癌临床实践中的临床考量:加拿大视角。
Curr Oncol. 2023 Aug 17;30(8):7672-7691. doi: 10.3390/curroncol30080556.
8
Advancing health equity: A qualitative study assessing barriers and facilitators of implementing hereditary breast and ovarian cancer risk screening tools in community-based organizations.推进健康公平:一项评估社区组织实施遗传性乳腺癌和卵巢癌风险筛查工具的障碍和促进因素的定性研究。
J Genet Couns. 2023 Oct;32(5):965-981. doi: 10.1002/jgc4.1705. Epub 2023 Apr 16.
9
Pathologic Findings at Risk Reducing Surgery in and Non- Mutation Carriers: A Single-Center Experience.携带和未携带突变者进行降低风险手术时的病理结果:单中心经验
Diagnostics (Basel). 2022 Dec 6;12(12):3054. doi: 10.3390/diagnostics12123054.
10
Germline Genetic Testing in Breast Cancer: Systemic Therapy Implications.乳腺癌的种系基因检测:系统治疗的意义。
Curr Oncol Rep. 2022 Dec;24(12):1791-1800. doi: 10.1007/s11912-022-01340-x. Epub 2022 Oct 18.
Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
超越李-佛美尼综合征:携带p53种系突变家族的临床特征
J Clin Oncol. 2009 Mar 10;27(8):1250-6. doi: 10.1200/JCO.2008.16.6959. Epub 2009 Feb 9.
4
Consistency of self-reported first-degree family history of cancer in a population-based study.基于人群的研究中自我报告的一级亲属癌症家族史的一致性。
Fam Cancer. 2009;8(3):195-202. doi: 10.1007/s10689-008-9228-2. Epub 2009 Jan 20.
5
Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome.巴西遗传性乳腺癌卵巢癌综合征患者中BRCA1基因5382insC突变的奠基者效应。
Cancer Genet Cytogenet. 2008 Jul;184(1):62-6. doi: 10.1016/j.cancergencyto.2008.03.011.
6
Validity of models for predicting BRCA1 and BRCA2 mutations.预测BRCA1和BRCA2基因突变模型的有效性。
Ann Intern Med. 2007 Oct 2;147(7):441-50. doi: 10.7326/0003-4819-147-7-200710020-00002.
7
[Increase in breast cancer mortality in Southern Brazil from 1980 to 2002].[1980年至2002年巴西南部乳腺癌死亡率上升]
Cad Saude Publica. 2007 Aug;23(8):1785-90. doi: 10.1590/s0102-311x2007000800005.
8
Limited family structure and BRCA gene mutation status in single cases of breast cancer.单例乳腺癌患者的有限家族结构及BRCA基因突变状态
JAMA. 2007 Jun 20;297(23):2587-95. doi: 10.1001/jama.297.23.2587.
9
Clinical characterization and risk profile of individuals seeking genetic counseling for hereditary breast cancer in Brazil.巴西遗传性乳腺癌基因咨询个体的临床特征与风险概况
J Genet Couns. 2007 Jun;16(3):363-71. doi: 10.1007/s10897-006-9073-0. Epub 2007 Feb 23.
10
Quality and effectiveness of different approaches to primary care delivery in Brazil.巴西初级医疗服务不同提供方式的质量与效果。
BMC Health Serv Res. 2006 Dec 5;6:156. doi: 10.1186/1472-6963-6-156.